Impact of COVID-19 related healthcare crisis on treatments for patients with lysosomal storage disorders, the first Italian experience

The direct and indirect effects of Coronavirus Disease-19 (COVID-19) pandemic, on Italian patients with lysosomal storage disorders receiving therapy, were analyzed by a phone questionnaire. No proved COVID-19 emerged among 102 interviewed. No problems were reported by patients receiving oral treatm...

Descripción completa

Detalles Bibliográficos
Autores principales: Sechi, Annalisa, Macor, Daniela, Valent, Serena, Da Riol, Rosalia Maria, Zanatta, Manuela, Spinelli, Alessandro, Bianchi, Katja, Bertossi, Nadia, Dardis, Andrea, Valent, Francesca, Scarpa, Maurizio
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier Inc. 2020
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7189198/
https://www.ncbi.nlm.nih.gov/pubmed/32386848
http://dx.doi.org/10.1016/j.ymgme.2020.04.002
Descripción
Sumario:The direct and indirect effects of Coronavirus Disease-19 (COVID-19) pandemic, on Italian patients with lysosomal storage disorders receiving therapy, were analyzed by a phone questionnaire. No proved COVID-19 emerged among 102 interviewed. No problems were reported by patients receiving oral treatments. Forty-nine% of patients receiving enzyme replacement therapy in hospitals experienced disruptions, versus 6% of those home-treated. The main reasons of missed infusions were fear of infection (62.9%) and re-organization of the infusion centers (37%).

Ejemplares similares